Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lesko

Showing results (701-710 of 1,126) with videos related to

Pageof 113
Sort By:
Pharmaceutical Development and Technology|December 3, 1998
Identification of formulation and manufacturing variables that influence in vitro dissolution and in vivo bioavailability of propranolol hydrochloride tabletsN D Eddington, M Ashraf, L L Augsburger, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 5, 2002
Variability in cimetidine absorption and plasma double peaks following oral administration in the fasted state in humans: correlation with antral gastric motilityNarushi Takamatsu, Lynda S Welage, Yayoi Hayashi, et al.
Journal of Consulting and Clinical Psychology|April 1, 1990
Anticipatory immune suppression and nausea in women receiving cyclic chemotherapy for ovarian cancerD H Bovbjerg, W H Redd, L A Maier, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 15, 2021
Physiologically-based pharmacokinetics modeling to investigate formulation factors influencing the generic substitution of dabigatran etexilateNashid Farhan, Rodrigo Cristofoletti, Sumit Basu, et al.
Therapeutic Drug Monitoring|July 18, 2015
Clinical Practice Recommendations on Genetic Testing of CYP2C9 and VKORC1 Variants in Warfarin TherapyKaitlyn Shaw, Ursula Amstutz, Richard B Kim, et al.
Pharmacogenomics|December 24, 2008
Fit-for-purpose pharmacogenomic biomarkers in drug development: a project team case study with 'what-ifs'Linda C Surh, Lawrence J Lesko, Stuart Hobbs, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|June 7, 2017
Evaluation of the Potential for Drug Interactions With Patiromer in Healthy VolunteersLawrence J Lesko, Elliot Offman, Christine Taylor Brew, et al.
Addiction Science & Clinical Practice|September 2, 2023
Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol useJarratt D Pytell, Anthony T Fojo, Jeanne C Keruly, et al.
Addiction (Abingdon, England)|July 25, 2023
Joint effects of substance use disorders and recent substance use on HIV viral non-suppression among people engaged in HIV care in an urban clinic, 2014-2019Catherine R Lesko, Oluwaseun O Falade-Nwulia, Jarratt D Pytell, et al.
Journal of the American Academy of Orthopaedic Surgeons. Global Research & Reviews|December 15, 2021
Comparison of Existing and New Total Knee Arthroplasty Implant Systems From the Same Manufacturer: A Prospective, Multicenter StudyWilliam G Hamilton, Ivan J Brenkel, Steven L Barnett, et al.
Pageof 113

Showing results (701-710 of 1,126) with videos related to

Sort By:
Pageof 113
Pharmaceutical Development and Technology|December 3, 1998
Identification of formulation and manufacturing variables that influence in vitro dissolution and in vivo bioavailability of propranolol hydrochloride tabletsN D Eddington, M Ashraf, L L Augsburger, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 5, 2002
Variability in cimetidine absorption and plasma double peaks following oral administration in the fasted state in humans: correlation with antral gastric motilityNarushi Takamatsu, Lynda S Welage, Yayoi Hayashi, et al.
Journal of Consulting and Clinical Psychology|April 1, 1990
Anticipatory immune suppression and nausea in women receiving cyclic chemotherapy for ovarian cancerD H Bovbjerg, W H Redd, L A Maier, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 15, 2021
Physiologically-based pharmacokinetics modeling to investigate formulation factors influencing the generic substitution of dabigatran etexilateNashid Farhan, Rodrigo Cristofoletti, Sumit Basu, et al.
Therapeutic Drug Monitoring|July 18, 2015
Clinical Practice Recommendations on Genetic Testing of CYP2C9 and VKORC1 Variants in Warfarin TherapyKaitlyn Shaw, Ursula Amstutz, Richard B Kim, et al.
Pharmacogenomics|December 24, 2008
Fit-for-purpose pharmacogenomic biomarkers in drug development: a project team case study with 'what-ifs'Linda C Surh, Lawrence J Lesko, Stuart Hobbs, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|June 7, 2017
Evaluation of the Potential for Drug Interactions With Patiromer in Healthy VolunteersLawrence J Lesko, Elliot Offman, Christine Taylor Brew, et al.
Addiction Science & Clinical Practice|September 2, 2023
Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol useJarratt D Pytell, Anthony T Fojo, Jeanne C Keruly, et al.
Addiction (Abingdon, England)|July 25, 2023
Joint effects of substance use disorders and recent substance use on HIV viral non-suppression among people engaged in HIV care in an urban clinic, 2014-2019Catherine R Lesko, Oluwaseun O Falade-Nwulia, Jarratt D Pytell, et al.
Journal of the American Academy of Orthopaedic Surgeons. Global Research & Reviews|December 15, 2021
Comparison of Existing and New Total Knee Arthroplasty Implant Systems From the Same Manufacturer: A Prospective, Multicenter StudyWilliam G Hamilton, Ivan J Brenkel, Steven L Barnett, et al.
Pageof 113